Dalton Pharma Services does not have its own clinical pipeline but provides cGMP manufacturing and development services for pharmaceutical and biotech clients at all stages, including commercial supply. The company has over three decades of experience supporting global drug development with regulatory compliance.
Therapeutic areas
Other
Modalities
Small moleculeBiologicPeptidesProtein (including recombinant protein)Antibody-drug conjugate (custom drug conjugation services)Sterile injectable formulationsAPIs (Active Pharmaceutical Ingredients)Finished dosage forms
Industry
Contract Manufacturing Organization
02
Drug pipeline
3 assets
cilastatin
Commercial
Indications
Acute kidney injury
2 more assets in the full pipeline.
03
Partnerships
Seikagaku Corporation (parent company)Technology partnership with 3P innovation for robotic aseptic powder filling line
Beyond the preview
Go deeper on Dalton Pharma Services.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
Trial phase
Status
Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
Partners
Deal terms
Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
Funding rounds
Investors
Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
Peer companies
Targets
Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
Platforms
Patents
Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
Company news
Sources
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dalton Pharma Services.